Industry Research Reports
Global TB Disease Vaccine Market Insights, Forecast to 2030
Industry: Pharma & Healthcare
Published Date: 2024-04-12
Pages: 113 Pages
Report ld: 2917525
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The vaccine for tuberculosis (TB) is known as BCG (bacille Calmette-Guérin) vaccine. BCG vaccine contains a weakened form of the bacteria (germ) that cause TB. Because it is weakened it doesn't cause TB in healthy people but it helps develop some protection (immunity) against TB.
The global TB Disease Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for TB Disease Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of TB Disease Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for TB Disease Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the TB Disease Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global TB Disease Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for TB Disease Vaccine sales, projected growth trends, production technology, application and end-user industry.
MARKET SEGMENTATION
By Company
- Merck
- Japan BCG Lab
- Serum Institute of India
- AJ Vaccines
- BioFarma
- GreenSignal Bio Pharma
- China National Biotec
- Biomed Lublin
- Taj Pharmaceuticals
- Ataulpho de Paiva
- IVAC
- Queen Saovabha Mem. Inst
- Microgen
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Prevention Vaccines
- Post-exposure Vaccines
- Others
Segment by Application
- Self-Procurement
- UNICEF
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of TB Disease Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of TB Disease Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, TB Disease Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 TB Disease Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global TB Disease Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Prevention Vaccines
1.2.3 Post-exposure Vaccines
1.2.4 Others
1.3 Market by Application
1.3.1 Global TB Disease Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Self-Procurement
1.3.3 UNICEF
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global TB Disease Vaccine Sales Estimates and Forecasts 2019-2030
2.2 Global TB Disease Vaccine Revenue by Region
2.2.1 Global TB Disease Vaccine Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global TB Disease Vaccine Revenue by Region (2019-2024)
2.2.3 Global TB Disease Vaccine Revenue by Region (2025-2030)
2.2.4 Global TB Disease Vaccine Revenue Market Share by Region (2019-2030)
2.3 Global TB Disease Vaccine Sales Estimates and Forecasts 2019-2030
2.4 Global TB Disease Vaccine Sales by Region
2.4.1 Global TB Disease Vaccine Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global TB Disease Vaccine Sales by Region (2019-2024)
2.4.3 Global TB Disease Vaccine Sales by Region (2025-2030)
2.4.4 Global TB Disease Vaccine Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global TB Disease Vaccine Sales by Manufacturers
3.1.1 Global TB Disease Vaccine Sales by Manufacturers (2019-2024)
3.1.2 Global TB Disease Vaccine Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of TB Disease Vaccine in 2023
3.2 Global TB Disease Vaccine Revenue by Manufacturers
3.2.1 Global TB Disease Vaccine Revenue by Manufacturers (2019-2024)
3.2.2 Global TB Disease Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by TB Disease Vaccine Revenue in 2023
3.3 Global Key Players of TB Disease Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global TB Disease Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global TB Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of TB Disease Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of TB Disease Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of TB Disease Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global TB Disease Vaccine Sales by Type
4.1.1 Global TB Disease Vaccine Historical Sales by Type (2019-2024)
4.1.2 Global TB Disease Vaccine Forecasted Sales by Type (2025-2030)
4.1.3 Global TB Disease Vaccine Sales Market Share by Type (2019-2030)
4.2 Global TB Disease Vaccine Revenue by Type
4.2.1 Global TB Disease Vaccine Historical Revenue by Type (2019-2024)
4.2.2 Global TB Disease Vaccine Forecasted Revenue by Type (2025-2030)
4.2.3 Global TB Disease Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global TB Disease Vaccine Price by Type
4.3.1 Global TB Disease Vaccine Price by Type (2019-2024)
4.3.2 Global TB Disease Vaccine Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global TB Disease Vaccine Sales by Application
5.1.1 Global TB Disease Vaccine Historical Sales by Application (2019-2024)
5.1.2 Global TB Disease Vaccine Forecasted Sales by Application (2025-2030)
5.1.3 Global TB Disease Vaccine Sales Market Share by Application (2019-2030)
5.2 Global TB Disease Vaccine Revenue by Application
5.2.1 Global TB Disease Vaccine Historical Revenue by Application (2019-2024)
5.2.2 Global TB Disease Vaccine Forecasted Revenue by Application (2025-2030)
5.2.3 Global TB Disease Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global TB Disease Vaccine Price by Application
5.3.1 Global TB Disease Vaccine Price by Application (2019-2024)
5.3.2 Global TB Disease Vaccine Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada TB Disease Vaccine Market Size by Type
6.1.1 US & Canada TB Disease Vaccine Sales by Type (2019-2030)
6.1.2 US & Canada TB Disease Vaccine Revenue by Type (2019-2030)
6.2 US & Canada TB Disease Vaccine Market Size by Application
6.2.1 US & Canada TB Disease Vaccine Sales by Application (2019-2030)
6.2.2 US & Canada TB Disease Vaccine Revenue by Application (2019-2030)
6.3 US & Canada TB Disease Vaccine Market Size by Country
6.3.1 US & Canada TB Disease Vaccine Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada TB Disease Vaccine Sales by Country (2019-2030)
6.3.3 US & Canada TB Disease Vaccine Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe TB Disease Vaccine Market Size by Type
7.1.1 Europe TB Disease Vaccine Sales by Type (2019-2030)
7.1.2 Europe TB Disease Vaccine Revenue by Type (2019-2030)
7.2 Europe TB Disease Vaccine Market Size by Application
7.2.1 Europe TB Disease Vaccine Sales by Application (2019-2030)
7.2.2 Europe TB Disease Vaccine Revenue by Application (2019-2030)
7.3 Europe TB Disease Vaccine Market Size by Country
7.3.1 Europe TB Disease Vaccine Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe TB Disease Vaccine Sales by Country (2019-2030)
7.3.3 Europe TB Disease Vaccine Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China TB Disease Vaccine Market Size
8.1.1 China TB Disease Vaccine Sales (2019-2030)
8.1.2 China TB Disease Vaccine Revenue (2019-2030)
8.2 China TB Disease Vaccine Market Size by Application
8.2.1 China TB Disease Vaccine Sales by Application (2019-2030)
8.2.2 China TB Disease Vaccine Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia TB Disease Vaccine Market Size by Type
9.1.1 Asia TB Disease Vaccine Sales by Type (2019-2030)
9.1.2 Asia TB Disease Vaccine Revenue by Type (2019-2030)
9.2 Asia TB Disease Vaccine Market Size by Application
9.2.1 Asia TB Disease Vaccine Sales by Application (2019-2030)
9.2.2 Asia TB Disease Vaccine Revenue by Application (2019-2030)
9.3 Asia TB Disease Vaccine Sales by Region
9.3.1 Asia TB Disease Vaccine Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia TB Disease Vaccine Revenue by Region (2019-2030)
9.3.3 Asia TB Disease Vaccine Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America TB Disease Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America TB Disease Vaccine Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America TB Disease Vaccine Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America TB Disease Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America TB Disease Vaccine Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America TB Disease Vaccine Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America TB Disease Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America TB Disease Vaccine Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America TB Disease Vaccine Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America TB Disease Vaccine Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck TB Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Merck TB Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Japan BCG Lab
11.2.1 Japan BCG Lab Company Information
11.2.2 Japan BCG Lab Overview
11.2.3 Japan BCG Lab TB Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Japan BCG Lab TB Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Japan BCG Lab Recent Developments
11.3 Serum Institute of India
11.3.1 Serum Institute of India Company Information
11.3.2 Serum Institute of India Overview
11.3.3 Serum Institute of India TB Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Serum Institute of India TB Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Serum Institute of India Recent Developments
11.4 AJ Vaccines
11.4.1 AJ Vaccines Company Information
11.4.2 AJ Vaccines Overview
11.4.3 AJ Vaccines TB Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 AJ Vaccines TB Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 AJ Vaccines Recent Developments
11.5 BioFarma
11.5.1 BioFarma Company Information
11.5.2 BioFarma Overview
11.5.3 BioFarma TB Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 BioFarma TB Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 BioFarma Recent Developments
11.6 GreenSignal Bio Pharma
11.6.1 GreenSignal Bio Pharma Company Information
11.6.2 GreenSignal Bio Pharma Overview
11.6.3 GreenSignal Bio Pharma TB Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 GreenSignal Bio Pharma TB Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GreenSignal Bio Pharma Recent Developments
11.7 China National Biotec
11.7.1 China National Biotec Company Information
11.7.2 China National Biotec Overview
11.7.3 China National Biotec TB Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 China National Biotec TB Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 China National Biotec Recent Developments
11.8 Biomed Lublin
11.8.1 Biomed Lublin Company Information
11.8.2 Biomed Lublin Overview
11.8.3 Biomed Lublin TB Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Biomed Lublin TB Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Biomed Lublin Recent Developments
11.9 Taj Pharmaceuticals
11.9.1 Taj Pharmaceuticals Company Information
11.9.2 Taj Pharmaceuticals Overview
11.9.3 Taj Pharmaceuticals TB Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Taj Pharmaceuticals TB Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Taj Pharmaceuticals Recent Developments
11.10 Ataulpho de Paiva
11.10.1 Ataulpho de Paiva Company Information
11.10.2 Ataulpho de Paiva Overview
11.10.3 Ataulpho de Paiva TB Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Ataulpho de Paiva TB Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Ataulpho de Paiva Recent Developments
11.11 IVAC
11.11.1 IVAC Company Information
11.11.2 IVAC Overview
11.11.3 IVAC TB Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 IVAC TB Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 IVAC Recent Developments
11.12 Queen Saovabha Mem. Inst
11.12.1 Queen Saovabha Mem. Inst Company Information
11.12.2 Queen Saovabha Mem. Inst Overview
11.12.3 Queen Saovabha Mem. Inst TB Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Queen Saovabha Mem. Inst TB Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Queen Saovabha Mem. Inst Recent Developments
11.13 Microgen
11.13.1 Microgen Company Information
11.13.2 Microgen Overview
11.13.3 Microgen TB Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Microgen TB Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Microgen Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 TB Disease Vaccine Industry Chain Analysis
12.2 TB Disease Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 TB Disease Vaccine Production Mode & Process
12.4 TB Disease Vaccine Sales and Marketing
12.4.1 TB Disease Vaccine Sales Channels
12.4.2 TB Disease Vaccine Distributors
12.5 TB Disease Vaccine Customers
13 Market Dynamics
13.1 TB Disease Vaccine Industry Trends
13.2 TB Disease Vaccine Market Drivers
13.3 TB Disease Vaccine Market Challenges
13.4 TB Disease Vaccine Market Restraints
14 Key Findings in The Global TB Disease Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global TB Disease Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Prevention Vaccines
Table 3. Major Manufacturers of Post-exposure Vaccines
Table 4. Major Manufacturers of Others
Table 5. Global TB Disease Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global TB Disease Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 7. Global TB Disease Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 8. Global TB Disease Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 9. Global TB Disease Vaccine Revenue Market Share by Region (2019-2024)
Table 10. Global TB Disease Vaccine Revenue Market Share by Region (2025-2030)
Table 11. Global TB Disease Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 12. Global TB Disease Vaccine Sales by Region (2019-2024) & (K Units)
Table 13. Global TB Disease Vaccine Sales by Region (2025-2030) & (K Units)
Table 14. Global TB Disease Vaccine Sales Market Share by Region (2019-2024)
Table 15. Global TB Disease Vaccine Sales Market Share by Region (2025-2030)
Table 16. Global TB Disease Vaccine Sales by Manufacturers (2019-2024) & (K Units)
Table 17. Global TB Disease Vaccine Sales Share by Manufacturers (2019-2024)
Table 18. Global TB Disease Vaccine Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 19. Global TB Disease Vaccine Revenue Share by Manufacturers (2019-2024)
Table 20. Global Key Players of TB Disease Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 21. TB Disease Vaccine Price by Manufacturers 2019-2024 (US$/Unit)
Table 22. Global TB Disease Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global TB Disease Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TB Disease Vaccine as of 2023)
Table 24. Global Key Manufacturers of TB Disease Vaccine, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of TB Disease Vaccine, Product Offered and Application
Table 26. Global Key Manufacturers of TB Disease Vaccine, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global TB Disease Vaccine Sales by Type (2019-2024) & (K Units)
Table 29. Global TB Disease Vaccine Sales by Type (2025-2030) & (K Units)
Table 30. Global TB Disease Vaccine Sales Share by Type (2019-2024)
Table 31. Global TB Disease Vaccine Sales Share by Type (2025-2030)
Table 32. Global TB Disease Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 33. Global TB Disease Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 34. Global TB Disease Vaccine Revenue Share by Type (2019-2024)
Table 35. Global TB Disease Vaccine Revenue Share by Type (2025-2030)
Table 36. TB Disease Vaccine Price by Type (2019-2024) & (US$/Unit)
Table 37. Global TB Disease Vaccine Price Forecast by Type (2025-2030) & (US$/Unit)
Table 38. Global TB Disease Vaccine Sales by Application (2019-2024) & (K Units)
Table 39. Global TB Disease Vaccine Sales by Application (2025-2030) & (K Units)
Table 40. Global TB Disease Vaccine Sales Share by Application (2019-2024)
Table 41. Global TB Disease Vaccine Sales Share by Application (2025-2030)
Table 42. Global TB Disease Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 43. Global TB Disease Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 44. Global TB Disease Vaccine Revenue Share by Application (2019-2024)
Table 45. Global TB Disease Vaccine Revenue Share by Application (2025-2030)
Table 46. TB Disease Vaccine Price by Application (2019-2024) & (US$/Unit)
Table 47. Global TB Disease Vaccine Price Forecast by Application (2025-2030) & (US$/Unit)
Table 48. US & Canada TB Disease Vaccine Sales by Type (2019-2024) & (K Units)
Table 49. US & Canada TB Disease Vaccine Sales by Type (2025-2030) & (K Units)
Table 50. US & Canada TB Disease Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 51. US & Canada TB Disease Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 52. US & Canada TB Disease Vaccine Sales by Application (2019-2024) & (K Units)
Table 53. US & Canada TB Disease Vaccine Sales by Application (2025-2030) & (K Units)
Table 54. US & Canada TB Disease Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 55. US & Canada TB Disease Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 56. US & Canada TB Disease Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 57. US & Canada TB Disease Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 58. US & Canada TB Disease Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 59. US & Canada TB Disease Vaccine Sales by Country (2019-2024) & (K Units)
Table 60. US & Canada TB Disease Vaccine Sales by Country (2025-2030) & (K Units)
Table 61. Europe TB Disease Vaccine Sales by Type (2019-2024) & (K Units)
Table 62. Europe TB Disease Vaccine Sales by Type (2025-2030) & (K Units)
Table 63. Europe TB Disease Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 64. Europe TB Disease Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 65. Europe TB Disease Vaccine Sales by Application (2019-2024) & (K Units)
Table 66. Europe TB Disease Vaccine Sales by Application (2025-2030) & (K Units)
Table 67. Europe TB Disease Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 68. Europe TB Disease Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 69. Europe TB Disease Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 70. Europe TB Disease Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 71. Europe TB Disease Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 72. Europe TB Disease Vaccine Sales by Country (2019-2024) & (K Units)
Table 73. Europe TB Disease Vaccine Sales by Country (2025-2030) & (K Units)
Table 74. China TB Disease Vaccine Sales by Type (2019-2024) & (K Units)
Table 75. China TB Disease Vaccine Sales by Type (2025-2030) & (K Units)
Table 76. China TB Disease Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 77. China TB Disease Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 78. China TB Disease Vaccine Sales by Application (2019-2024) & (K Units)
Table 79. China TB Disease Vaccine Sales by Application (2025-2030) & (K Units)
Table 80. China TB Disease Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 81. China TB Disease Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 82. Asia TB Disease Vaccine Sales by Type (2019-2024) & (K Units)
Table 83. Asia TB Disease Vaccine Sales by Type (2025-2030) & (K Units)
Table 84. Asia TB Disease Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 85. Asia TB Disease Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 86. Asia TB Disease Vaccine Sales by Application (2019-2024) & (K Units)
Table 87. Asia TB Disease Vaccine Sales by Application (2025-2030) & (K Units)
Table 88. Asia TB Disease Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 89. Asia TB Disease Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 90. Asia TB Disease Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 91. Asia TB Disease Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 92. Asia TB Disease Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 93. Asia TB Disease Vaccine Sales by Region (2019-2024) & (K Units)
Table 94. Asia TB Disease Vaccine Sales by Region (2025-2030) & (K Units)
Table 95. Middle East, Africa and Latin America TB Disease Vaccine Sales by Type (2019-2024) & (K Units)
Table 96. Middle East, Africa and Latin America TB Disease Vaccine Sales by Type (2025-2030) & (K Units)
Table 97. Middle East, Africa and Latin America TB Disease Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America TB Disease Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 99. Middle East, Africa and Latin America TB Disease Vaccine Sales by Application (2019-2024) & (K Units)
Table 100. Middle East, Africa and Latin America TB Disease Vaccine Sales by Application (2025-2030) & (K Units)
Table 101. Middle East, Africa and Latin America TB Disease Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America TB Disease Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 103. Middle East, Africa and Latin America TB Disease Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 104. Middle East, Africa and Latin America TB Disease Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America TB Disease Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 106. Middle East, Africa and Latin America TB Disease Vaccine Sales by Country (2019-2024) & (K Units)
Table 107. Middle East, Africa and Latin America TB Disease Vaccine Sales by Country (2025-2030) & (K Units)
Table 108. Merck Company Information
Table 109. Merck Description and Major Businesses
Table 110. Merck TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Merck TB Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Merck Recent Developments
Table 113. Japan BCG Lab Company Information
Table 114. Japan BCG Lab Description and Major Businesses
Table 115. Japan BCG Lab TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Japan BCG Lab TB Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Japan BCG Lab Recent Developments
Table 118. Serum Institute of India Company Information
Table 119. Serum Institute of India Description and Major Businesses
Table 120. Serum Institute of India TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Serum Institute of India TB Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Serum Institute of India Recent Developments
Table 123. AJ Vaccines Company Information
Table 124. AJ Vaccines Description and Major Businesses
Table 125. AJ Vaccines TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. AJ Vaccines TB Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. AJ Vaccines Recent Developments
Table 128. BioFarma Company Information
Table 129. BioFarma Description and Major Businesses
Table 130. BioFarma TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 131. BioFarma TB Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. BioFarma Recent Developments
Table 133. GreenSignal Bio Pharma Company Information
Table 134. GreenSignal Bio Pharma Description and Major Businesses
Table 135. GreenSignal Bio Pharma TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 136. GreenSignal Bio Pharma TB Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. GreenSignal Bio Pharma Recent Developments
Table 138. China National Biotec Company Information
Table 139. China National Biotec Description and Major Businesses
Table 140. China National Biotec TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 141. China National Biotec TB Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. China National Biotec Recent Developments
Table 143. Biomed Lublin Company Information
Table 144. Biomed Lublin Description and Major Businesses
Table 145. Biomed Lublin TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 146. Biomed Lublin TB Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Biomed Lublin Recent Developments
Table 148. Taj Pharmaceuticals Company Information
Table 149. Taj Pharmaceuticals Description and Major Businesses
Table 150. Taj Pharmaceuticals TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 151. Taj Pharmaceuticals TB Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Taj Pharmaceuticals Recent Developments
Table 153. Ataulpho de Paiva Company Information
Table 154. Ataulpho de Paiva Description and Major Businesses
Table 155. Ataulpho de Paiva TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 156. Ataulpho de Paiva TB Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Ataulpho de Paiva Recent Developments
Table 158. IVAC Company Information
Table 159. IVAC Description and Major Businesses
Table 160. IVAC TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 161. IVAC TB Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. IVAC Recent Developments
Table 163. Queen Saovabha Mem. Inst Company Information
Table 164. Queen Saovabha Mem. Inst Description and Major Businesses
Table 165. Queen Saovabha Mem. Inst TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 166. Queen Saovabha Mem. Inst TB Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Queen Saovabha Mem. Inst Recent Developments
Table 168. Microgen Company Information
Table 169. Microgen Description and Major Businesses
Table 170. Microgen TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 171. Microgen TB Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Microgen Recent Developments
Table 173. Key Raw Materials Lists
Table 174. Raw Materials Key Suppliers Lists
Table 175. TB Disease Vaccine Distributors List
Table 176. TB Disease Vaccine Customers List
Table 177. TB Disease Vaccine Market Trends
Table 178. TB Disease Vaccine Market Drivers
Table 179. TB Disease Vaccine Market Challenges
Table 180. TB Disease Vaccine Market Restraints
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
List of Figures
Figure 1. TB Disease Vaccine Product Picture
Figure 2. Global TB Disease Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global TB Disease Vaccine Market Share by Type in 2023 & 2030
Figure 4. Prevention Vaccines Product Picture
Figure 5. Post-exposure Vaccines Product Picture
Figure 6. Others Product Picture
Figure 7. Global TB Disease Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global TB Disease Vaccine Market Share by Application in 2023 & 2030
Figure 9. Self-Procurement
Figure 10. UNICEF
Figure 11. Others
Figure 12. TB Disease Vaccine Report Years Considered
Figure 13. Global TB Disease Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global TB Disease Vaccine Revenue 2019-2030 (US$ Million)
Figure 15. Global TB Disease Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 16. Global TB Disease Vaccine Revenue Market Share by Region (2019-2030)
Figure 17. Global TB Disease Vaccine Sales 2019-2030 ((K Units)
Figure 18. Global TB Disease Vaccine Sales Market Share by Region (2019-2030)
Figure 19. US & Canada TB Disease Vaccine Sales YoY (2019-2030) & (K Units)
Figure 20. US & Canada TB Disease Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 21. Europe TB Disease Vaccine Sales YoY (2019-2030) & (K Units)
Figure 22. Europe TB Disease Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 23. China TB Disease Vaccine Sales YoY (2019-2030) & (K Units)
Figure 24. China TB Disease Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Asia (excluding China) TB Disease Vaccine Sales YoY (2019-2030) & (K Units)
Figure 26. Asia (excluding China) TB Disease Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Middle East, Africa and Latin America TB Disease Vaccine Sales YoY (2019-2030) & (K Units)
Figure 28. Middle East, Africa and Latin America TB Disease Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 29. The TB Disease Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 30. The Top 5 and 10 Largest Manufacturers of TB Disease Vaccine in the World: Market Share by TB Disease Vaccine Revenue in 2023
Figure 31. Global TB Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 32. Global TB Disease Vaccine Sales Market Share by Type (2019-2030)
Figure 33. Global TB Disease Vaccine Revenue Market Share by Type (2019-2030)
Figure 34. Global TB Disease Vaccine Sales Market Share by Application (2019-2030)
Figure 35. Global TB Disease Vaccine Revenue Market Share by Application (2019-2030)
Figure 36. US & Canada TB Disease Vaccine Sales Market Share by Type (2019-2030)
Figure 37. US & Canada TB Disease Vaccine Revenue Market Share by Type (2019-2030)
Figure 38. US & Canada TB Disease Vaccine Sales Market Share by Application (2019-2030)
Figure 39. US & Canada TB Disease Vaccine Revenue Market Share by Application (2019-2030)
Figure 40. US & Canada TB Disease Vaccine Revenue Share by Country (2019-2030)
Figure 41. US & Canada TB Disease Vaccine Sales Share by Country (2019-2030)
Figure 42. U.S. TB Disease Vaccine Revenue (2019-2030) & (US$ Million)
Figure 43. Canada TB Disease Vaccine Revenue (2019-2030) & (US$ Million)
Figure 44. Europe TB Disease Vaccine Sales Market Share by Type (2019-2030)
Figure 45. Europe TB Disease Vaccine Revenue Market Share by Type (2019-2030)
Figure 46. Europe TB Disease Vaccine Sales Market Share by Application (2019-2030)
Figure 47. Europe TB Disease Vaccine Revenue Market Share by Application (2019-2030)
Figure 48. Europe TB Disease Vaccine Revenue Share by Country (2019-2030)
Figure 49. Europe TB Disease Vaccine Sales Share by Country (2019-2030)
Figure 50. Germany TB Disease Vaccine Revenue (2019-2030) & (US$ Million)
Figure 51. France TB Disease Vaccine Revenue (2019-2030) & (US$ Million)
Figure 52. U.K. TB Disease Vaccine Revenue (2019-2030) & (US$ Million)
Figure 53. Italy TB Disease Vaccine Revenue (2019-2030) & (US$ Million)
Figure 54. Russia TB Disease Vaccine Revenue (2019-2030) & (US$ Million)
Figure 55. China TB Disease Vaccine Sales Market Share by Type (2019-2030)
Figure 56. China TB Disease Vaccine Revenue Market Share by Type (2019-2030)
Figure 57. China TB Disease Vaccine Sales Market Share by Application (2019-2030)
Figure 58. China TB Disease Vaccine Revenue Market Share by Application (2019-2030)
Figure 59. Asia TB Disease Vaccine Sales Market Share by Type (2019-2030)
Figure 60. Asia TB Disease Vaccine Revenue Market Share by Type (2019-2030)
Figure 61. Asia TB Disease Vaccine Sales Market Share by Application (2019-2030)
Figure 62. Asia TB Disease Vaccine Revenue Market Share by Application (2019-2030)
Figure 63. Asia TB Disease Vaccine Revenue Share by Region (2019-2030)
Figure 64. Asia TB Disease Vaccine Sales Share by Region (2019-2030)
Figure 65. Japan TB Disease Vaccine Revenue (2019-2030) & (US$ Million)
Figure 66. South Korea TB Disease Vaccine Revenue (2019-2030) & (US$ Million)
Figure 67. China Taiwan TB Disease Vaccine Revenue (2019-2030) & (US$ Million)
Figure 68. Southeast Asia TB Disease Vaccine Revenue (2019-2030) & (US$ Million)
Figure 69. India TB Disease Vaccine Revenue (2019-2030) & (US$ Million)
Figure 70. Middle East, Africa and Latin America TB Disease Vaccine Sales Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America TB Disease Vaccine Revenue Market Share by Type (2019-2030)
Figure 72. Middle East, Africa and Latin America TB Disease Vaccine Sales Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America TB Disease Vaccine Revenue Market Share by Application (2019-2030)
Figure 74. Middle East, Africa and Latin America TB Disease Vaccine Revenue Share by Country (2019-2030)
Figure 75. Middle East, Africa and Latin America TB Disease Vaccine Sales Share by Country (2019-2030)
Figure 76. Brazil TB Disease Vaccine Revenue (2019-2030) & (US$ Million)
Figure 77. Mexico TB Disease Vaccine Revenue (2019-2030) & (US$ Million)
Figure 78. Turkey TB Disease Vaccine Revenue (2019-2030) & (US$ Million)
Figure 79. Israel TB Disease Vaccine Revenue (2019-2030) & (US$ Million)
Figure 80. GCC Countries TB Disease Vaccine Revenue (2019-2030) & (US$ Million)
Figure 81. TB Disease Vaccine Value Chain
Figure 82. TB Disease Vaccine Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global TB Disease Vaccine market?
The top companies in the global TB Disease Vaccine market are Merck、Japan BCG Lab、Serum Institute of India.
Related Reports
Global TB Disease Vaccine Market Research Report 2025
The global market for TB Disease Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-01
Pages: 91
USD 2900.00
(Single User License)
Global TB Disease Vaccine Market Research Report 2024
The vaccine for tuberculosis (TB) is known as BCG (bacille Calmette-Guérin) vaccine. BCG vaccine contains a weakened form of the bacteria (germ) that cause TB. Because it is weakened it doesn't cause TB in healthy people but it helps develop some protection (immunity) against TB.
Published Date: 2024-01-17
Pages: 93
USD 2900.00
(Single User License)
TB Disease Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The vaccine for tuberculosis (TB) is known as BCG (bacille Calmette-Guérin) vaccine. BCG vaccine contains a weakened form of the bacteria (germ) that cause TB. Because it is weakened it doesn't cause TB in healthy people but it helps develop some protection (immunity) against TB.
Published Date: 2024-01-07
Pages: 130
USD 3950.00
(Single User License)
Global TB Disease Vaccine Market Research Report 2025
The global market for TB Disease Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-01
Pages: 91
USD 2900.00 (Single User License)Global TB Disease Vaccine Market Research Report 2024
The vaccine for tuberculosis (TB) is known as BCG (bacille Calmette-Guérin) vaccine. BCG vaccine contains a weakened form of the bacteria (germ) that cause TB. Because it is weakened it doesn't cause TB in healthy people but it helps develop some protection (immunity) against TB.
Published: 2024-01-17
Pages: 93
USD 2900.00 (Single User License)TB Disease Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The vaccine for tuberculosis (TB) is known as BCG (bacille Calmette-Guérin) vaccine. BCG vaccine contains a weakened form of the bacteria (germ) that cause TB. Because it is weakened it doesn't cause TB in healthy people but it helps develop some protection (immunity) against TB.
Published: 2024-01-07
Pages: 130
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now